Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
1 other identifier
interventional
600
1 country
1
Brief Summary
This study aims to compare the effectiveness of a Virtual Reality (VR) application computer simulation \[(CS) VR Mindful Meditation App')\] versus music relaxation in reducing anxiety and pain in women undergoing breast biopsies. Participants will be randomized into three groups: VR, music relaxation, or standard care. Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels. Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedStudy Start
First participant enrolled
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
February 5, 2026
January 1, 2026
1.4 years
February 19, 2025
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Anxiety
Pre- and post-procedure anxiety will be measured using the State-Trait Anxiety Inventory (STAI). The scale uses a four point Likert scale ranging from "not at all" to "very much so." The score range is from 20-80 with a higher score indicating more anxiety. The change in anxiety scores (pre- to post-procedure) will be compared across the three groups (VR, music relaxation, and control).
perioperatively/periprocedurally
Pain Level
Pain will be measured using the Visual Analog Scale (VAS) before and after the procedure. The scale is a subjective measure where individuals mark pain intensity on a 100mm line. typically from "no pain" (0) to "wort possible pain" (100). Higher score is worse. The change in pain scores (pre- to post-procedure) will be analyzed. The
perioperatively/periprocedurally
Secondary Outcomes (2)
Physiological Markers
During Biopsy
Satisfaction Scores
immediately after the intervention/procedure/surgery
Study Arms (3)
VR Intervention
EXPERIMENTALPatients will wear a Virtual Reality (VR) headset during the breast biopsy. They will use the CS VR Mindful Meditation App. Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels. Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
Music Intervention
ACTIVE COMPARATORPatients will listen to standard calming music during the breast biopsy from the computer/speakers in the room. Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels. Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
No Intervention
NO INTERVENTIONPatients will have no intervention and complete the breast biopsy as standard of care. Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels. Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
Interventions
Patients will wear a Virtual Reality (VR) headset and use an application called CS VR Mindful Meditation App.
Patients will listen to standard calming music played in the room.
Eligibility Criteria
You may qualify if:
- Females aged 18 years or older.
- Scheduled for an ultrasound-guided or stereotactic breast biopsy.
- Capable of understanding and providing informed consent.
You may not qualify if:
- Individuals with a history of epilepsy, motion sickness, or severe cognitive impairment (for the VR group).
- Use of anxiolytic medication immediately prior to the biopsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westwood
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2025
First Posted
December 30, 2025
Study Start
January 20, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
February 5, 2026
Record last verified: 2026-01